ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,825 | -35.8% | 23,604 | +0.7% | 0.00% | – |
| Q2 2023 | $116,517 | +0.6% | 23,444 | 0.0% | 0.00% | – |
| Q1 2023 | $115,813 | -21.5% | 23,444 | 0.0% | 0.00% | – |
| Q4 2022 | $147,463 | -41.2% | 23,444 | +0.8% | 0.00% | -100.0% |
| Q3 2022 | $251,000 | -5.3% | 23,254 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $265,000 | +25.6% | 23,254 | +0.3% | 0.00% | – |
| Q1 2022 | $211,000 | -39.0% | 23,184 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $346,000 | -40.7% | 23,184 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $583,000 | -1.5% | 22,684 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $592,000 | -22.3% | 22,684 | +5.0% | 0.00% | -50.0% |
| Q1 2021 | $762,000 | +37.8% | 21,597 | -1.4% | 0.00% | +100.0% |
| Q4 2020 | $553,000 | -33.1% | 21,897 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $826,000 | +6.4% | 21,897 | +20.8% | 0.00% | 0.0% |
| Q2 2020 | $776,000 | +219.3% | 18,127 | +93.8% | 0.00% | +100.0% |
| Q4 2019 | $243,000 | +4.7% | 9,355 | +10.1% | 0.00% | 0.0% |
| Q3 2019 | $232,000 | +1.8% | 8,495 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $228,000 | – | 8,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |